CompletedNot Applicable

Management of Abnormal Uterine Bleeding

Egypt130 participantsStarted 2024-03-01

Plain-language summary

Abnormal uterine bleeding "AUB" describes all abnormal forms of menstrual bleeding which may result from several causes including anovulation, problems related to pregnancy, infections, vaginal and cervical abnormalities, uterine pathologies including benign and malignant tumors, coagulopathies, endocrine disorders, trauma, foreign bodies, systemic diseases and iatrogenic causes. AUB may be clinically presented by menorrhagia, metrorrhagia or menometrorrhagia. It's the most common complaint for the reproductive age females and accounts for 33% of female patients referred to gynecologists

Who can participate

Age range15 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any female patient in Child bearing period aging from 15-45 years complaining of Abnormal uterine. * Abnormal uterine bleeding due to endometrial, uterine cavity lesions as diagnosed by TVS or bleeding tendency e.g. Thrombocytopenia, Platelets dysfunction and coagulation defects Exclusion Criteria: * Personal history of renal or hepatic impairment; previous thromboembolic disease, peptic ulcer. * Females with evident drugs intake that cause AUB e.g warfarin, low molecular weight heparin. * Vaginal, vulvar, and cervical causes of bleeding. * Bleeding on top of Use of hormonal and non-hormonal contraception.

What they're measuring

Bleeding Control

Timeframe: 1 week

Trial details

NCT IDNCT06369012

SponsorEgymedicalpedia

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-09-01

View on ClinicalTrials.gov More Abnormal Uterine Bleeding trials